Clinical Trials Directory

Trials / Completed

CompletedNCT06266000

Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency

A Study to Compare 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
89 (actual)
Sponsor
RDC Clinical Pty Ltd · Industry
Sex
Male
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A randomized, double-blind, placebo-controlled, parallel group study to compare 2 extracts of saw palmetto versus placebo on lower urinary tract symptoms and urinary frequency in 120 generally healthy participants, 45 - 80 years.

Conditions

Interventions

TypeNameDescription
DRUGSaw palmetto extract 320mg per daySaw palmetto extract 160mg per capsule
DRUGCommercial Saw palmetto extract 320mg per daySaw palmetto extract 160mg per capsule
DRUGPalm Oil capsulePalm oil capsule

Timeline

Start date
2024-06-21
Primary completion
2025-06-04
Completion
2025-06-04
First posted
2024-02-20
Last updated
2025-08-20

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT06266000. Inclusion in this directory is not an endorsement.